hydroxyethyl cellulose
Trade name: ExEm Foam
Small moleculeapprovedImaging agent
Approved
Nov 7, 2019
Air polymer-type A, sold under the brand name ExEm Foam, is a drug for the detection of fallopian tube patency (openness) in people with known or suspected infertility. It was approved for use in the United States in November 2019. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
2010s
- Nov 7, 2019
Giskit B.V. — Earliest FDA Approval
- Nov 7, 2019
Evidence of US Marketing
- Nov 7, 2019
Giskit B.V. — Marketing Organization
- Nov 7, 2019
Giskit B.V. — NDA Organization
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Ultrasound contrast agent
Intrauterine foam for use as an ultrasound contrast agent during visualisation of the fallopian tubes and peritoneal cavity for evaluation of fertility.
Approval history
- approvedNov 7, 2019
- approvedNov 7, 2019
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- Yes
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaAir polymer-type A ↗
- NCATSS38J6RZN16 ↗
- ChEMBLCHEMBL4594264 ↗
- NCATSZYD53NBL45 ↗
- NCATS8136Y38GY5 ↗
Organizations
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Giskit B.V. | For profit | MKTG | Nov 7, 2019 |
| Giskit B.V. | For profit | SYN | Nov 7, 2019 |
| Giskit B.V. | For profit | NDA | Nov 7, 2019 |